| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9227239 | Journal of Allergy and Clinical Immunology | 2005 | 8 Pages |
Abstract
The observed safety profile and biologic activity of rhC1INH warrants further clinical studies to assess its efficacy in treating HAE attacks.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Martijn B.A. MD, Jacobus MD, PhD, Tijtje MSc, Anke Eerenberg, Marcel MD, PhD, Cornelis E. MD, PhD, Rik C. PhD, Adam F. MD, PhD, Jan MD, PhD,